High-dose cyclophosphamide for aplastic anemia and autoimmunity

Current Opinion in Oncology

Volumn 14, Issue 2, 2002, Pages 143-146

  Brodsky, Robert A ^a  

^a Bunting Blaustein Can Res Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HLA ANTIGEN; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD TOXICITY; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYCOSIS; PRIORITY JOURNAL; REVIEW;

ANEMIA, APLASTIC; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 0036128268     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200203000-00001     Document Type: Review

References (25)

1. Aplastic anaemia treated by marrow transplantation
2. Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies
3. Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia
4. Recovery from aplastic anemia following attempted marrow transplantation
5. Recovery from aplastic anemia after treatment with cyclophosphamide
6. Assessment of aldehyde dehydrogenase in viable cells
7. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells
8. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine
9. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers
10. Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation
11. Long-term outcome of acquired aplastic anaemia in children: Comparison between immunosuppressive therapy and bone marrow transplantation
12. Improved survival in severe acquired aplastic anemia of childhood
13. Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide
14. Treatment of severe aplastic anemia using high-dose cyclophosphamide alone in China
15. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children
16. High-dose cyclophosphamide in severe aplastic anaemia: A randomised trial
17. Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine
18. Durable treatment-free remission following high-dose cyclophosphamide for previously untreated severe aplastic anemia
19. Autologous stem cell transplant for autoimmune disease: A preliminary report
20. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: Results of an open study to assess feasibility, safety, and efficacy
21. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study
22. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplant
23. Immunoablative high-dose cyclophosphamide without stem cell rescue for refractory severe autoimmune disease
24. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: Report of a case and review of this new therapy for severe autoimmune disease
25. Elimination of alloantibodies by immunoablative high-dose cyclophosphamide